E2F1 and hepatocellular carcinoma: SETD7 is known to stabilize E2F transcription factor 1 (E2F1) in hepatocellular carcinoma, leading to the expression of cyclin E1, cyclin A2, and CDK1, which triggers the cell cycle in tumorigenesis30.